Celanese Corporation CE

DALLAS, September 21, 2026--Celanese Announces Global Price Increases Across the Acetyl Chain

Celanese (NYSE:CE) appointed Luis Fernandez-Moreno to its Board of Directors, adding over 40 years of industry experience. Fernandez-Moreno has held senior roles across major chemical producers, with a focus on performance materials and industrial chemicals. His background spans corporate strategy, growth initiatives and product innovation across multiple global operations in the sector. The appointment of Luis Fernandez-Moreno to the board is only one piece of the Celanese story for...

Celanese has seen its share price move around in recent years, and that puts fresh focus on a simple question for investors who care about fundamentals. Is the current US$46.87 price tag adequately backed by the sales the business is generating today? Over the past 5 years the stock has fallen 65.3%, which makes the link between Celanese's share price and the revenue it produces far more important for anyone still holding or thinking about an entry point. The chemicals group relies on...

DALLAS, September 16, 2026--Luis Fernandez-Moreno Elected to Celanese Board of Directors

Markets are bracing for Friday's CPI data after a brutal week of selling across stocks, bonds, and crypto, and Wall Street analysts are already reshuffling their ratings on names like Dell, Shopify, Novo Nordisk, and Fortinet before the dust settles.

Celanese Corporation (NYSE:CE) agreed to sell another 19% of the Nutrinova food-ingredients joint venture to Mitsui & Co., Ltd. for approximately $152 million in cash. The transaction, expected to close in the fourth quarter subject to customary conditions, will reduce the retained interest of Celanese Corporation (NYSE:CE) from 30% to 11%. The interest being sold […]

DALLAS & FRANKFURT, August 31, 2026--Celanese to Sell Additional Shares of Nutrinova Joint Venture to Mitsui & Co., Ltd.

Delray Beach, FL, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The global Medical Plastics Market is projected to grow from USD 34.77 billion in 2026 to USD 48.77 billion by 2031, at a CAGR of 7.0% during the forecast period. Growth is driven by rising demand for advanced medical devices, increasing adoption of minimally invasive procedures, growing preference for single-use and disposable medical products, and expanding pharmaceutical and biotechnology industries. Get PDF Brochure — Market Data & Segmenta

DALLAS & SHANGHAI, August 17, 2026--VIGOR and Celanese Sign Strategic Partnership Agreement; Building a New Ecosystem for Lightweight Joint Solutions in Humanoid Robots

Celanese (NYSE:CE) walked into its August 4 earnings call having beaten the plan it laid out back in May, then spent the call flagging a bumpier third quarter ahead. CEO Scott Richardson and CFO Chuck Kyrish explained why: the company’s global production network flexed hard in the second quarter, pulling forward benefits that are now […]